Literature DB >> 6430391

Effects of treatment for hypertension on cerebral haemorrhage and infarction.

D G Black, A M Heagerty, R F Bing, H Thurston, J D Swales.   

Abstract

One hundred and sixty nine patients admitted to hospital for stroke over 30 months were examined to see whether treating hypertension had influenced the incidence of cerebral haemorrhage and infarction. Seventy eight (46%) of them had normal blood pressure, 47 (28%) previously diagnosed hypertension for which they were receiving treatment, and 44 (26%) previously undiagnosed and untreated hypertension. Haemorrhagic stroke was commoner among patients with untreated hypertension, whereas infarction was commoner in patients with treated hypertension. Infarction and haemorrhage were equally prevalent in patients with normal blood pressure. Effective treatment in this population seemed to have had a substantially different impact on vascular disease, giving rise to cerebral haemorrhage as opposed to infarction. This is consistent with evidence from other studies that treatment for hypertension has little or no effect on the progression of atheroma.

Entities:  

Mesh:

Year:  1984        PMID: 6430391      PMCID: PMC1441966          DOI: 10.1136/bmj.289.6438.156

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  6 in total

1.  Ischaemic brain damage of cerebral perfusion failure type after treatment of severe hypertension.

Authors:  D I Graham
Journal:  Br Med J       Date:  1975-12-27

2.  Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study.

Authors:  W B Kannel; P A Wolf; J Verter; P M McNamara
Journal:  JAMA       Date:  1970-10-12       Impact factor: 56.272

3.  Geographical variation in mortality from conditions amenable to medical intervention in England and Wales.

Authors:  J R Charlton; R M Hartley; R Silver; W W Holland
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

4.  Hypertension and stroke.

Authors:  M J Harrison
Journal:  Br J Hosp Med       Date:  1984-03

5.  The declining incidence of stroke.

Authors:  W M Garraway; J P Whisnant; A J Furlan; L H Phillips; L T Kurland; W M O'Fallon
Journal:  N Engl J Med       Date:  1979-03-01       Impact factor: 91.245

6.  Treatment of refractory hypertension.

Authors:  J D Swales; R F Bing; A Heagerty; J E Pohl; G I Russell; H Thurston
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

  6 in total
  5 in total

1.  Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly.

Authors:  P A Jansen; F W Gribnau; B P Schulte; E F Poels
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

2.  Mortality from and incidence of stroke in Stockholm.

Authors:  L Alfredsson; M von Arbin; U de Faire
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

3.  Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.

Authors:  V A Naukkarinen; K Karppinen; S Sarna
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Effects of treatment with verapamil SR and captopril on the lipid profile of hypertensive patients.

Authors:  M Catalano; C Cislaghi; G Carzaniga; A Aronica; R Seregni; A Libretti
Journal:  Drugs       Date:  1992       Impact factor: 9.546

5.  Enantiomers of 2-methylglutamate and 2-methylglutamine selectively impact mouse brain metabolism and behavior.

Authors:  Adam M Wawro; Chandresh R Gajera; Steven A Baker; Robert K Leśniak; Curt R Fischer; Nay L Saw; Mehrdad Shamloo; Thomas J Montine
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.